Continuing Medical and Interprofessional Education

The Rittenhouse Hotel | 210 W Rittenhouse Square | Philadelphia, PA 19103

REGISTER AT PennMedicine.org/Abramson/BloodCME

FRIDAY, FEBRUARY 1, 20197:30 AM - 4:30 PM

2019 UPDATES IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT: with Proceedings from International Medical Meetings

Penn Medicine’s Abramson Cancer Center and the Leukemia & Lymphoma Society P R E S E N T

A CME/CNE-accredited Conference

Penn Medicine’s Abramson Cancer Center and the Leukemia & Lymphoma Society P R E S E N T

2019 UPDATE IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT: with Proceedings from International Medical Meetings

REGISTER AT PennMedicine.org/Abramson/BloodCME

THE RITTENHOUSE HOTEL 210 W Rittenhouse SquarePhiladelphia, PA 19103

DIRECTIONS AND PARKINGVisit rittenhousehotel.com

Valet parking available.Parking fees are not covered by conference.

Please note that conference materials will be available online. Please bring your electronic device to view presentations in real time.

FRIDAY, FEBRUARY 1

2 0 1 97:30 AM – 4:30 PM

OVERVIEWThis course is a comprehensive review of hematologic malignancies focusing on research developments over the preceding year and their application to the patient care journey. Didactic presentations will include case discussion with Penn faculty and community experts. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of patient care. Participants will leave with up-to-date, practical information which will have immediate clinical application.

OBJECTIVESUpon completion of this course, participants should be able to:• Identify clinical features, including differential diagnoses for

the various hematologic malignancies• Implement strategies that incorporate state-of-the-art

genomic analyses for hematologic malignancies• Select patients with potential eligibility for immunotherapy • List appropriate clinical trials for hematologic malignancies • Identify the major patient management issues experienced

by the interprofessional care team associated with hematologic malignancies

• Apply new strategies for incorporating therapies that target metabolism in blood cancers

WHO SHOULD ATTENDThis activity has been designed for hematologists, medical and radiation oncologists, primary care physicians, pathologists, hematology/oncology fellows, oncology nurses, oncology social workers, and other healthcare professionals involved in the treatment of patients with blood cancers.

2019 UPDATES IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT:

with Proceedings from International Medical Meetings A CME/CNE-accredited Conference

2019 UPDATES IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT:

with Proceedings from International Medical Meetings A CME/CNE-accredited Conference

AGENDA7:30 am Registration and Continental Breakfast 8:00 am Welcome and Introduction Edward A. Stadtmauer, MD, Activity Director Ellen Rubesin, Executive Director, Leukemia and Lymphoma Society

KEYNOTE PRESENTATION

8:10 am Optimizing Flow Cytometry for the Diagnosis and Management of Blood CancerJulianne N. Qualtieri, MD

NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS MODERATOR: Sunita D. Nasta, MD, FACP

9:00 am New Therapies and Current Management of Follicular LymphomasJames M. Gerson, MD

9:30 am Therapeutic Advances in Hodgkin’s and T-Cell LymphomaJakub Svoboda, MD

10:00 am Large Cell Lymphoma and Aggressive LymphomasSunita D. Nasta, MD, FACP

10:30 am Case Presentation with Panel Discussion MODERATOR: Sunita D. Nasta, MD, FACP PANEL: James M. Gerson, MD Gamil S. Hanna, MD Danielle Land, MSN, CRNP David Mintzer, MD Jakub Svoboda, MD

11:00 am BREAK

UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA MODERATOR: Selina M. Luger, MD

11:15 am Update in Treatment Strategies for ALL and AMLShannon R. McCurdy, MD

11:45 am Update in Myeloproliferative DiseaseDaria V. Babushok, MD, PHD

12:15 pm Emerging Treatment Options for Myelodysplastic SyndromesJames K. Mangan, MD, PhD

12:45 pm Panel Discussion with Question and Answer SessionMODERATOR: Selina M. Luger, MDPANEL: Daria V. Babushok, MD, PhD Marie Block, MSN, CRNP William Luginbuhl, MD James K. Mangan, MD, PhD Shannon R. McCurdy, MD

1:15 pm LUNCH

2:00 pmUpdate in Bone Marrow and Stem Cell Transplantation Noelle V. Frey, MD, MSCE Patricia A. Ford, MD

CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMAMODERATOR: Edward A. Stadtmauer, MD

2:30 pm Initial Therapy for Multiple Myeloma Including TransplantAlfred L. Garfall, MD, MTR

3:00 pm Experimental Therapies for Relapsed MyelomaDan T. Vogl, MD, MSCE

3:30 pm Role of Immunotherapy for MyelomaAdam D. Cohen, MD

4:00 pm Case Presentation with Panel DiscussionMODERATOR: Edward A. Stadtmauer, MDPANEL: Adam D. Cohen, MD Alfred L. Garfall, MD Patricia Mangan, MSN, CRNP Dan T. Vogl, MD, MSCE Stephen G. Wallace, MD

4:30 pm ADJOURN

Non-Penn Physicians .................................................... $50Non-Penn residents, fellows, nurses andother healthcare professionals .................................... $25Penn faculty .................................................................... $25Penn fellows, residents, nurses, students and staff .....................................................................No Fee

Registration fee includes course materials, continental breakfast, and lunch. For additional information please contact Barbara Lopez at lopezb@pennmedicine.upenn.edu.

REGISTRATION

Register online at PennMedicine.org/Abramson/BloodCME

ACCREDITATIONIn support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

DESIGNATION OF CREDITPHYSICIANS: Penn Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: The program will award 7.5 contact hours.

PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 7.5 Category 1 credits for completing this activity.

DISCLOSURES Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.

CANCELLATION POLICYThe University reserves the right to cancel or postpone any course due to unforeseen circumstances. In the event of cancellation or postponement, the University will refund registration fees but is not responsible for any related costs or expenses to participants, including cancellation fees assessed by hotels, airlines and travel agencies.

In order to process refunds for conference withdrawals, we must receive cancellation in writing by December 14, 2018.

SERVICES FOR THE DISABLEDIf special arrangements are required for an individual with a disability to attend this meeting, please contact lopezb@pennmedicine.upenn.edu, no later than December 14, 2018.

NONDISCRIMINATION STATEMENTThe University of Pennsylvania values diversity and seeks talented students, faculty and staff from diverse backgrounds. The University of Pennsylvania does not discriminate on the basis of race, color, sex, sexual orientation, gender identity, religion, creed, national or ethnic origin, citizenship status, age, disability, veteran status or any other legally protected class status in the administration of its admissions, financial aid, educational or athletic programs, or other University administered programs or in its employment practices. Questions or complaints regarding this policy should be directed to the Executive Director of the Office of Affirmative Action and Equal Opportunity Programs, 3451 Walnut Street, Franklin Building, 4th Floor, Room 421; (215) 898-6993 (Voice) or (215) 898-7803 (TDD).

ACCREDITATION AND DESIGNATION OF CREDIT

Selina M. Luger, MDProfessor, MedicineDivision of Hematology OncologyDirector, Leukemia Program David L. Porter, MDJodi Fisher Horowitz Professor of Leukemia Care ExcellenceDivision of Hematology OncologyDirector, Blood and Marrow Transplantation Stephen J. Schuster, MD Robert and Margarita Louis-Dreyfus Associate Professor of Chronic Lymphocytic Leukemia and LymphomaDivision of Hematology OncologyDirector, Lymphoma Program and Lymphoma Translational Research

Edward A. Stadtmauer, MD Roseman, Tarte, Harrow, and Shaffer Families’ President’s Distinguished ProfessorChief, Hematologic Malignancies Section, Division of Hematology Oncology Co-Leader, Hematologic Malignancies Research Program

ACTIVITY DIRECTOR

PENN MEDICINE FACULTY

ACTIVITY CO-DIRECTORS

SPEAKERSPENN MEDICINE FACULTY

Patricia A. Ford, MD Clinician, Hematology Oncology Pennsylvania HospitalNoelle V. Frey, MD, MSCEAssistant Professor, Medicine (Hematology/Oncology)Alfred L. Garfall, MD, MTRAssistant Professor, Medicine (Hematology/Oncology)James M. Gerson, MDAssistant Professor, Medicine (Hematology/Oncology)Gamil S. Hanna, MDClinician, Hematology Oncology Chester County HospitalDanielle Land, MSN, CRNPNurse Practitioner, Medicine (Hematology/Oncology)William E. Luginbuhl, MDClinician, Hematology Oncology Chester County HospitalJames K. Mangan, MD, PhDAssistant Professor, Medicine (Hematology/Oncology)Patricia Mangan, MSN, CRNPNurse Practitioner, Medicine (Hematology/Oncology)Shannon R. McCurdy, MDAssistant Professor, Medicine (Hematology /Oncology)David Mintzer, MDClinician, Hematology Oncology Pennsylvania HospitalSunita D. Nasta, MD, FACPAssociate Professor, Medicine (Hematology/Oncology)Julianne N. Qualtieri, MD Assistant Professor, Pathology & Laboratory Medicine (Hematopathology)Jakub Svoboda, MDAssistant Professor, Medicine (Hematology/Oncology)Dan T. Vogl, MDAssistant Professor, Medicine (Hematology/Oncology)Stephen G. Wallace, MD Clinician, Hematology Oncology Penn Medicine at Virtua

Daria V. Babushok, MD, PhD Instructor, Medicine (Hematology/Oncology) Marie Block, MSN, CRNP Nurse Practitioner, Medicine (Hematology Oncology)Adam D. Cohen, MD Assistant Professor, Medicine (Hematology/Oncology)

A Cancer Center Designated by the National Cancer Institute

ComprehensiveCancer Center

3600 Market StreetSuite 240Philadelphia, PA 19104-2643

Non-Profit Org. U.S. Postage

PAIDPermit No. 2563Phila, PA 19176

Abramson Cancer Center

A CME/CNE-accredited Conference

Penn Medicine’s Abramson Cancer Center and the Leukemia & Lymphoma Society P R E S E N T

2019 UPDATE IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT: with Proceedings from International Medical Meetings

FEBRUARY 1, 2019 | 7:30 AM - 4:30 PM

REGISTER AT PennMedicine.org/Abramson/BloodCME